Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses the newly available JAK inhibitors for use in a variety of dermatological conditions. Dr. Chovatiya reviews how JAK inhibitors work differently from other agents to reduce inflammation and the benefits that they can have for certain patient populations.
Looking to the future of AD treatment, Dr. Song discusses the unmet need of predicting treatment responses in patients with atopic dermatitis, with the aim of avoiding the trial-and-error process of trying multiple medications.
...
